These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26158773)

  • 1. Current advances and challenges in the development of Acinetobacter vaccines.
    Chen W
    Hum Vaccin Immunother; 2015; 11(10):2495-500. PubMed ID: 26158773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
    KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
    Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First steps towards a vaccine against Acinetobacter baumannii.
    Garcia-Quintanilla M; Pulido MR; McConnell MJ
    Curr Pharm Biotechnol; 2013; 14(10):897-902. PubMed ID: 24372252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.
    McConnell MJ; Pachón J
    Vaccine; 2010 Dec; 29(1):1-5. PubMed ID: 21044668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
    Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
    Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reverse Vaccinology Approach to Potential Vaccine Candidates Against Acinetobacter baumannii.
    Shahid F; Ashraf ST; Ali A
    Methods Mol Biol; 2019; 1946():329-336. PubMed ID: 30798567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where are we and how far is there to go in the development of an
    Ma C; Chen W
    Expert Rev Vaccines; 2021 Mar; 20(3):281-295. PubMed ID: 33554671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
    García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
    PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A medically relevant capsular polysaccharide in Acinetobacter baumannii is a potential vaccine candidate.
    Yang FL; Lou TC; Kuo SC; Wu WL; Chern J; Lee YT; Chen ST; Zou W; Lin NT; Wu SH
    Vaccine; 2017 Mar; 35(10):1440-1447. PubMed ID: 28190743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.
    Shu MH; MatRahim N; NorAmdan N; Pang SP; Hashim SH; Phoon WH; AbuBakar S
    Sci Rep; 2016 Feb; 6():22332. PubMed ID: 26923424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Different Methods for Preparing
    Li S; Chen DQ; Ji L; Sun S; Jin Z; Jin ZL; Sun HW; Zeng H; Zhang WJ; Lu DS; Luo P; Zhao AN; Luo J; Zou QM; Li HB
    Front Immunol; 2020; 11():1069. PubMed ID: 32655550
    [No Abstract]   [Full Text] [Related]  

  • 14. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
    McConnell MJ; Rumbo C; Bou G; Pachón J
    Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
    Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
    Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.
    Chiang MH; Sung WC; Lien SP; Chen YZ; Lo AF; Huang JH; Kuo SC; Chong P
    Hum Vaccin Immunother; 2015; 11(4):1065-73. PubMed ID: 25751377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.
    Moriel DG; Beatson SA; Wurpel DJ; Lipman J; Nimmo GR; Paterson DL; Schembri MA
    PLoS One; 2013; 8(10):e77631. PubMed ID: 24116234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic Resistance Determinant-Focused Acinetobacter baumannii Vaccine Designed Using Reverse Vaccinology.
    Ni Z; Chen Y; Ong E; He Y
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
    Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
    PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.